Leaflet PHARMATAZ 30mg orodispersible tablets


Indicated for: depression

Route of administration: oral

Substance: mirtazapine (antidepressant)

ATC: N06AX11 (Nervous system | Antidepressants | Other antidepressants)

Mirtazapinum is an antidepressant medication used for the treatment of major depression and other mood disorders. It works by increasing levels of serotonin and norepinephrine in the brain, thereby improving mood and reducing depressive symptoms.

The medication is taken orally, usually once daily at bedtime. It is effective in alleviating depressive symptoms and improving sleep quality.

Side effects may include drowsiness, weight gain, dry mouth, and dizziness. In rare cases, severe reactions such as suicidal thoughts or worsening depression may occur. Close monitoring is essential, especially at the beginning of treatment.

Consult your doctor to discuss the benefits and risks of treatment with Mirtazapinum. Follow the prescribed dosage and adhere to all medical recommendations.

General data about PHARMATAZ 30mg

  • Substance: mirtazapine
  • Date of last drug list: 01-04-2014
  • Commercial code: W56794007
  • Concentration: 30mg
  • Pharmaceutical form: orodispersible tablets
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for mirtazapine

Concentrations available for mirtazapine

  • 15mg
  • 30mg
  • 45mg